2-(1H-indol-3-yl)acetonitrile

ID: ALA1812654

Cas Number: 771-51-7

PubChem CID: 351795

Product Number: I107936, Order Now?

Max Phase: Preclinical

Molecular Formula: C10H8N2

Molecular Weight: 156.19

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Synonyms: 3-Indoleacetonitrile | 3-Indoleacetonitrile|771-51-7|Indole-3-acetonitrile|2-(1H-indol-3-yl)acetonitrile|3-Indolylacetonitrile|1H-Indole-3-acetonitrile|3-(Cyanomethyl)indole|Indolylacetonitrile|Indoleacetonitrile|Indolylacetonitril|3-Indolacetonitrile|Acetonitrile, 3-indolyl-|1H-Indol-3-ylacetonitrile|Indol-3-ylacetonitrile|(3-Indolyl)acetonitrile|USAF CB-29|(indol-3-yl)acetonitrile|3-Cyanomethyl-1H-indole|(1H-indol-3-yl)-acetonitrile|NSC 523272|Indolyl-3-acetonitrile|AG97OFW8JW|(Indole-3-yl)aceShow More

Canonical SMILES:  N#CCc1c[nH]c2ccccc12

Standard InChI:  InChI=1S/C10H8N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5H2

Standard InChI Key:  DMCPFOBLJMLSNX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 12 13  0  0  0  0  0  0  0  0999 V2000
    1.7142  -11.9096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7131  -12.7365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4275  -13.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4257  -11.4971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1407  -11.9060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1409  -12.7365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9309  -12.9930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4189  -12.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9305  -11.6492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1850  -10.8649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9915  -10.6932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7941  -10.5182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  6  2  0
  1  2  2  0
  5  4  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4  1  1  0
  9 10  1  0
  5  6  1  0
 10 11  1  0
 11 12  3  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BGC-823 (3035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bel-7402 (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KETR3 (279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-8 (3484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tdo2 Tryptophan 2,3-dioxygenase (195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 156.19Molecular Weight (Monoisotopic): 156.0687AlogP: 2.23#Rotatable Bonds: 1
Polar Surface Area: 39.58Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.74CX Basic pKa: CX LogP: 1.77CX LogD: 1.77
Aromatic Rings: 2Heavy Atoms: 12QED Weighted: 0.68Np Likeness Score: -0.36

References

1. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R..  (2011)  Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.,  54  (15): [PMID:21726069] [10.1021/jm2006782]
2. Chen M, Gan L, Lin S, Wang X, Li L, Li Y, Zhu C, Wang Y, Jiang B, Jiang J, Yang Y, Shi J..  (2012)  Alkaloids from the root of Isatis indigotica.,  75  (6): [PMID:22694318] [10.1021/np3002833]

Source